Form 4: LifeMD Executive Maria E. Stan Reports Acquisition of Common Stock
SEC Form 4
Maria E. Stan, Chief Accounting Officer of LifeMD, Inc., reports the acquisition of common stock through vesting of restricted stock units and performance stock.
Summary
- On July 15, 2021, Maria E. Stan acquired 9,375 shares of common stock through vesting of restricted stock units.
- On February 4, 2022, she acquired 10,000 shares of common stock through vesting of restricted stock units.
- On November 7, 2023, she acquired 40,000 shares of common stock through vesting of restricted stock units.
- Also on November 7, 2023, she acquired another 40,000 shares of common stock through vesting of restricted stock units.
- On March 31, 2025, she acquired 20,000 shares of common stock through vesting of performance stock.
- Also on March 31, 2025, she acquired another 20,000 shares of common stock through vesting of restricted stock units.
- Following these transactions, Maria E. Stan directly owns 207,500 shares of LifeMD, Inc. common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock acquisitions through vesting. It indicates continued employment and potentially meeting performance targets, which is mildly positive.
Positives
- The vesting of restricted stock units and performance stock indicates that Maria E. Stan is meeting performance goals or time-based vesting requirements.
- Increased ownership aligns her interests with those of other shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The increased ownership of company stock by a key executive could be viewed positively by shareholders, as it aligns management's interests with theirs.
- Employees may see this as a positive sign of company stability and growth.
Key Dates
| Date | Description |
|---|---|
| 07/15/2021 | 3,125 restricted stock units vested |
| 02/04/2022 | 5,000 restricted stock units vested |
| 07/15/2022 | 3,125 restricted stock units vested |
| 02/04/2023 | 5,000 restricted stock units vested |
| 07/15/2023 | 3,125 restricted stock units vested |
| 11/07/2023 | Restricted stock units vested |
| 01/01/2024 | Restricted stock units vested |
| 02/04/2024 | 5,000 restricted stock units vested |
| 07/15/2024 | 3,125 restricted stock units vested |
| 01/01/2025 | Restricted stock units vested |
| 03/31/2025 | Performance stock vested |
| 03/31/2025 | Restricted stock units vested |
| 01/01/2027 | Restricted stock units vest in full |
| 04/03/2025 | Date of signature |
Keywords
LifeMD, Maria E. Stan, Form 4, Beneficial Ownership, Common Stock, Restricted Stock Units, Performance Stock, LFMD, Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.